Overview

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).

Phase:

Phase 3

Details

Lead Sponsor:

Ironwood Pharmaceuticals, Inc.

Collaborator:

Forest Laboratories

Treatments:

Linaclotide